The Lancet · Online First· Seong-Bong Wee, Do-Yoon Kang, Jung-Min Ahn, Ju Hyeon Kim, Min-Ju Kim, Seung-Woon Rha, Sung-Ho Her, Hyo-Soo Kim, Hanbit Park, Chang-Wook Nam, Upendra Kaul, Won-Yong Shin, Jay-Young Rhew, June-Hong Kim, Jang Young Kim, Teguh Santoso, Woo-Young Chung, Youngkeun Ahn, Bong-Ki Lee, Jei Keon Chae, Jin-Bae Lee, Soon Jun Hong, Jin-Ok Jeong, Kyu-Rok Han, Alan Fong, Rakesh Sapra, Dong-Bin Kim, Ho Jin Kim, Kitae Kim, Joon Bum Kim, Jae Suk Yoo, Cheol Hyun Chung, Seung-Jung Park, Duk-Woo Park, IRIS-MAIN Investigators·· 4 小时前AI 评分49
左主干冠状动脉疾病患者药物洗脱支架经皮冠状动脉介入治疗与冠状动脉旁路移植术后的长期结局：多中心 IRIS-MAIN 登记研究的前瞻性分析
[Articles] Long-term outcomes after percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting for left main coronary artery disease: a prospective analysis of the multicentre IRIS-MAIN registry
AI 导读
IRIS-MAIN 非随机登记分析显示，左主干冠状动脉疾病患者接受经皮冠状动脉介入治疗或冠状动脉旁路移植术后，全因死亡率差异无统计学意义。对两种策略均适用的患者，多学科心脏团队讨论可能有助于权衡治疗利弊。这些观察性结果不能确立治疗的因果效应或生存等效性。
来源：The Lancet · Online First · thelancet.com